Glioma
Showing 101 - 125 of 370
Glioma Trial in Baltimore (Hyperpolarized 13C-Pyruvate)
Recruiting
- Glioma
- Hyperpolarized 13C-Pyruvate
-
Baltimore, MarylandRosy Njonkou Tchoquessi
May 27, 2022
Brain Tumor, Brain Tumors, Brain Cancer Trial in Milan, Palermo, Valladolid (Ultrasound)
Recruiting
- Brain Tumor
- +4 more
- Ultrasound
-
Milan, Italy
- +2 more
May 25, 2022
Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)
Active, not recruiting
- Glioblastoma Multiforme
- +6 more
- Dendritic cell immunotherapy
-
Birmingham, Alabama
- +85 more
May 12, 2022
Glioma Trial in Atlanta (Optune device)
Recruiting
- Glioma
- Optune device
-
Atlanta, Georgia
- +2 more
May 12, 2022
Propofol, Glioma, Auditory Event-related Potential (AERP) Trial (Propofol Injection)
Not yet recruiting
- Propofol
- +4 more
- Propofol Injection
- (no location specified)
May 8, 2022
Glioma, Glioblastoma, Brain Tumor Trial in United States (LITT, Hypofractionated Radiation Therapy)
Recruiting
- Glioma
- +2 more
- LITT
- Hypofractionated Radiation Therapy
-
Baltimore, Maryland
- +4 more
Apr 26, 2022
Glioma Trial in United States (Pembrolizumab, Olaparib and Temozolomide)
Recruiting
- Glioma
- Pembrolizumab
- Olaparib and Temozolomide
-
Basking Ridge, New Jersey
- +6 more
Apr 13, 2022
Aneurysm, AVM, Dural Arteriovenous Fistula Trial in Bern (Laser speckle contrast imaging (LSCI))
Completed
- Aneurysm
- +5 more
- Laser speckle contrast imaging (LSCI)
-
Bern, SwitzerlandDepartment of Neurosurgery
Apr 11, 2022
Multimodal Machine Learning Characterization of Solid Tumors
Recruiting
- Adenocarcinoma of Prostate
- +5 more
- [18F]DCFPyL
- PET/MRI scanner
-
Boston, Massachusetts
- +1 more
Apr 4, 2022
Post-operative Imaging in High Grade Glioma: is Management
Recruiting
- Glioma
- MRI
-
London, United KingdomKing´s College Hospital NHS Foundation trust
Mar 30, 2022
Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)
Recruiting
- Glioblastoma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 10, 2022
IDH-mutant and IDH-wildtype Glioma Patients After
Recruiting
- Glioma
- RS-fMRI
-
Saint Louis, MissouriWashington University School of Medicine
Mar 8, 2022
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))
Active, not recruiting
- Glioma
- +4 more
- VAL-083 (Dianhydrogalactitol)
-
Guangzhou, ChinaSun Yat-Sen University Cancer Center
Mar 23, 2022
Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)
Active, not recruiting
- Glioma
- +4 more
- VAL-083, Dianhydrogalactitol
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 23, 2022
Functional Magnetic Resonance Imaging in Patients Who Speak Two
Recruiting
- Glioma
- +2 more
- Multilingual Aphasia Examination
- +2 more
-
New York, New York
- +3 more
Mar 17, 2022
Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI Scanner
-
Miami, FloridaUniversity of Miami
Mar 15, 2022
Advanced Solid Tumor, IDH1 Mutation, Glioma Trial in Pittsburgh (ivosidenib and nivolumab)
Recruiting
- Advanced Solid Tumor
- +2 more
- ivosidenib and nivolumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 14, 2022
Glioma Trial in London (Advanced MRI sequences)
Not yet recruiting
- Glioma
- Advanced MRI sequences
-
London, United KingdomKing's R&I department
Feb 22, 2022
Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)
Not yet recruiting
- Glioma
- +12 more
- Observational
- (no location specified)
Feb 17, 2022